T, an in-situ platform combination immunotherapy optimized for solid tumor cancers, has announced the appointment of Stephen ...

Privately-held Boston, USA-based Nimbus Therapeutics today announced it has entered into a multi-year research collaboration ...

US biotech major Amgen has announced its acquisition of privately-held UK firm Dark Blue Therapeutics, a biotech advancing ...

Artis BioSolutions, a San Diego, USA-based advanced-therapies development and manufacturing company that launched in April ...

Positive full results from AstraZeneca’s Phase III TULIP-SC trial have shown the subcutaneous (SC) administration of Saphnelo ...

Switzerland-based Oculis Holding has announced that its neuroprotective candidate privosegtor was granted breakthrough ...

California-based Cartography Biosciences, an oncology company advancing a pipeline of T-cell engaging bispecific and ...

Arrowhead Pharmaceuticals today announced interim results from two Phase I/IIa clinical trials of ARO-INHBE and ARO-ALK7, the ...

Earendil Labs, a US AI-driven R&D next-generation biologics therapeutics start-up, has announced an expanded strategic ...

Chinese biotech Shanghai Ark Biopharmaceutical said the country’s medicines regulator has approved Azstarys ...

UK analytics group Clarivate (NYSE: CLVT) has published its 2026 Drugs to Watch report, identifying 11 therapies it believes ...

Dutch immunology company argenx announced that Karen Massey, current chief operating officer, will transition to chief ...